Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.
Location: United States, Massachusetts, Waltham
Investors 3
Date | Name | Website |
10.03.2024 | Hercules C... | htgc.com |
- | MRL Ventur... | mrlv.com |
09.11.2022 | Longitude ... | longitudec... |
Mentions in press and media 4
Date | Title | Description | Source |
26.07.2021 | VIRIDIAN THERAPEUTICS : APPOINTS KRISTIAN HUMER AS CHIEF FIN... | VIRIDIAN THERAPEUTICS APPOINTS KRISTIAN HUMER AS CHIEF FINANCIAL OFFICER AND CHIEF BUSINESS OFFICER ... | marketscre... |
26.07.2021 | Viridian Therapeutics : Appoints Kristian Humer as Chief Fin... | BOULDER, Colo., July 26, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biop... | marketscre... |
15.07.2021 | VIRIDIAN THERAPEUTICS : APPOINTS JENNIFER MOSES, CPA TO THE ... | VIRIDIAN THERAPEUTICS APPOINTS JENNIFER MOSES, CPA TO THE BOARD OF DIRECTORS AND AS CHAIR OF THE AUD... | marketscre... |
14.07.2021 | Viridian Therapeutics : Announces Inducement Grant Under Nas... | BOULDER, Colo., July 14, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (“the “... | marketscre... |